![]() | |
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChemCID | |
ChemSpider |
|
UNII | |
ChEMBL | |
CompTox Dashboard(EPA) | |
Chemical and physical data | |
Formula | C17H19N |
Molar mass | 237.346 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Etifelmine (INN; also known asgilutensin) is astimulant drug. It was used for the treatment ofhypotension (low blood pressure).[1]
The base-catalyzed reaction betweenbenzophenone (1) andbutyronitrile (2) gives 2-[hydroxy(diphenyl)methyl]butanenitrile (3).[2][3]Catalytic hydrogenation reduces the nitrile group to a primary amine giving 1,1-diphenyl-2-ethyl-3-aminopropanol (4). The tertiary hydroxyl group isdehydrated by treatment with anhydrous hydrogen chloride gas, completing the synthesis of etifelmine (5).
![]() | Thisdrug article relating to thenervous system is astub. You can help Wikipedia byexpanding it. |